Impact of Medication for Opioid Use Disorder on Patient Directed Discharge Among Patients with Opioid Use Disorder.  Singh-Tan, S., Jakubowski, A., Reicher, Z.H. et al. J GEN INTERN MED (2026). doi.org/10.1007/s11606-026-10172-5 ht…

Opioid Treatment Programs’ Medicaid Patient Retention Rates.  DeLisle DE, Mark TL, Katz C, Dowd WN, Barch D, Kluckman M.  JAMA Netw Open. 2026;9(1):e2553538. doi:10.1001/jamanetworkopen.2025.53538 https://jamanetwork.com/journals/jamane…

Global perspectives on telemedicine-enabled medications for opioid use disorder: Practices, priorities, and barriers.  Schofield J, Baldacchino AM, Ambekar A, Anaba H, Butner JL, Day N, Ekhtiari H, Elomari F, Ferri M, Kokkolis K, Kouimtsidis C…

Exploring the use of telemedicine to expand addiction and recovery resources in Great Plains Tribal Communities.  Harding MC, Kihlstrom AC, Kelliher A, Rosa C, Kropp FB, Winhusen TJ, Warne DK.  J Rural Health. 2026 Jan;42(1):e70113. doi…

Addiction Consultation Services for Opioid Use Disorder Treatment Initiation and Engagement: A Randomized Clinical Trial.  McNeely J, Wang SS, Rostam Abadi Y, Barron C, Billings J, Tarpey T, Fernando J, Appleton N, Fawole A, Mazumdar M, Weinst…

Differences in MOUD receipt by legal referral type in outpatient treatment.  Moore J, Renn T, Veeh C, Beeler S.  J Subst Use Addict Treat. 2026 Jan 21;184:209888. doi: 10.1016/j.josat.2026.209888. Epub ahead of print. PMID: 41577038. ht…